First we assessed Ro 25–6981's ability to alter Plp1 expression levels as reduction of mutant PLP is beneficial to PMD cellular and animal models (Karim et al., 2010, Prukop et al., 2014). This evidence concerns the gene PLP1 and Pelizeaus-Merzbacher spectrum disorder.